As a group of academics, private industry, researchers, government and other public institutions, our collective response to COVID-19 demonstrates the need for a unified, cloud-based technology platform.
I had the pleasure of presenting a webinar alongside my colleague, Michael McGloughlin with the Emerging Biopharma division of Oracle Health Sciences, on the “Future of Clinical Trials: Reimagining the Way Technology and Data Support Clinical Research.”
We conducted a quick poll and learned that the majority of webinar attendees (63%) are managing up to five different technology platforms in support of clinical trials. I suspect that if we took into account the number of different vendors we work with who provide these technology types – such as electronic data capture (EDC) systems, electronic case report forms (eCRFs), interactive response technology (IRT), safety database providers, etc. — that number would grow exponentially.
Lindsay is a clinical research professional with over 16 years of experience in biotechnology, with demonstrated expertise in clinical project management, clinical operations, data management and vendor management. At FHI Clinical, she coordinates cross-functional teams in support of clinical development programs for small- to mid-sized pharmas and large CROs.
As my colleague Michael discussed during the webinar, it’s time for us as an industry to think and act differently. I encourage you to listen to our on-demand webinar to learn more about the benefits of a unified, modular, cloud-based platform like Oracle Clinical One. This new model presents a major shift, allowing you to think differently, streamline workflows and reallocate resources. With Clinical One, you stand to speed up the process of innovation and quickly adapt those advances into your current processes.